David Olmos
David Olmos, MD, PhD
David Olmos is a Clinical Scientist and Medical Oncologist at Hospital Universitario 12 de Octubre and its research institute in Madrid, Spain, where he holds a tenured position as a Distinguished Researcher. Olmos has contributed to the development of several prostate cancer drugs.
Disclosures: Received multiple grants as Principal Investigator (PI) or Co-PI from AECC (Asociación Española Contra el Cáncer), CRIS (CRIS Cancer Foundation), DoD-CDMRP (U.S. Department of Defense – Congressionally Directed Medical Research Programs), ISCIII (Instituto de Salud Carlos III), PCF (Prostate Cancer Foundation), Ramón y Cajal Research Excellence Programme (Spanish Ministry of Science), and SEOM (Sociedad Española de Oncología Médica).
View content featuring Olmos:
Developed by EPG Health. This content has been developed independently of the sponsor, Pfizer, which has had no editorial input into the content. EPG Health received funding from the sponsor to help provide healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content. This content is intended for healthcare professionals only.
of interest
are looking at
saved
next event